Henry Schein (HSIC) Tops Q2 EPS by 11c

Henry Schein (NASDAQ: HSIC) reported Q2 EPS of $0.00, $0.11 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.68 billion versus the consensus estimate of $1.38 billion.

Financial Guidance

Due to the continued uncertainty surrounding the COVID-19 pandemic and its impact to business operations, Henry Schein is not providing 2020 financial guidance at this time.

For earnings history and earnings-related data on Henry Schein (HSIC) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Atossa Genetics (ATOS) Tops Q2 EPS by 10c
• King Pharmaceuticals (KG) Misses Q2 EPS by 103c